chlorpromazine has been researched along with tropisetron in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Faller, B; Trunzer, M; Zimmerlin, A | 1 |
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
de Vries, EG; Groenewegen, A; Kema, IP; Schröder, CP; Sleijfer, DT; van der Graaf, WT | 1 |
Befon, S; Liossi, C; Mystakidou, K; Vlachos, L | 2 |
Giráldez, J; Idoate, A; Jiménez, M; Sierrasesumaga, L; Tejedor, I | 1 |
Good, P; Hardy, JR; Haywood, A; Khan, S; Rickett, K; Vayne-Bossert, P | 1 |
1 review(s) available for chlorpromazine and tropisetron
Article | Year |
---|---|
Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery).
Topics: Adrenal Cortex Hormones; Adult; Chlorpromazine; Dexamethasone; Humans; Indoles; Metoclopramide; Nausea; Neoplasms; Time Factors; Tropisetron; Vomiting | 2017 |
2 trial(s) available for chlorpromazine and tropisetron
Article | Year |
---|---|
Comparison of tropisetron and chlorpromazine combinations in the control of nausea and vomiting of patients with advanced cancer.
Topics: Adult; Aged; Antiemetics; Chlorpromazine; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Serotonin Antagonists; Tropisetron; Vomiting | 1998 |
Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer.
Topics: Adult; Aged; Antiemetics; Chlorpromazine; Dexamethasone; Drug Therapy, Combination; Female; Humans; Indoles; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prospective Studies; Tropisetron; Vomiting | 1998 |
5 other study(ies) available for chlorpromazine and tropisetron
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation.
Topics: Chromatography, Liquid; Drug Design; Humans; Likelihood Functions; Microsomes, Liver; Pharmacokinetics; Tandem Mass Spectrometry | 2009 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetron.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorpromazine; Cisplatin; Drug Interactions; Etoposide; Humans; Hydroxyindoleacetic Acid; Indoles; Infusions, Intravenous; Neoplasms, Germ Cell and Embryonal; Serotonin; Serotonin Antagonists; Tropisetron; Vomiting | 1995 |
Cost-effectiveness analysis of tropisetron vs. chlorpromazine-dexamethasone in the control of acute emesis induced by highly emetogenic chemotherapy in children.
Topics: Adolescent; Age Factors; Antiemetics; Child; Child, Preschool; Chlorpromazine; Cost-Benefit Analysis; Dexamethasone; Humans; Indoles; Sensitivity and Specificity; Tropisetron; Vomiting | 1999 |